ALGER ASSOCIATES INC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:11 pm Unchanged | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | ALGER ASSOCIATES INC | 73,559 5.100% | 0 (Unchanged) | Filing |
| 2023-09-11 8:54 pm Purchase | 2023-08-31 | 13G | Forte Biosciences, Inc. FBRX | ALGER ASSOCIATES INC | 73,559 5.100% | 73,559 (New Position) | Filing |